These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 5143853)

  • 1. Environmental and familial predictors of attention behavior in chronic schizophrenics.
    Orzack MH; Kornetsky C
    J Psychiatr Res; 1971 Dec; 9(1):21-9. PubMed ID: 5143853
    [No Abstract]   [Full Text] [Related]  

  • 2. Institutional management of chronic schizophrenics with fluphenazine decanoate.
    Neal CD; Imlah NW
    Dis Nerv Syst; 1970 Sep; 31():Suppl:24-7. PubMed ID: 4920310
    [No Abstract]   [Full Text] [Related]  

  • 3. Vulnerability-linked deficiencies, psychopathology and coping behaviour of schizophrenics and their relatives.
    Böker W; Brenner HD; Würgler S
    Br J Psychiatry Suppl; 1989 Jul; (5):128-35. PubMed ID: 2605019
    [No Abstract]   [Full Text] [Related]  

  • 4. Pimozide treatment of chronic schizophrenics as compared with haloperidol and penfluridol maintenance treatment. A multidisciplinary approach.
    Baro F; Van Lommel R; Dom R; De Mesmaecker L
    Acta Psychiatr Belg; 1972 Mar; 72(2):199-214. PubMed ID: 5056015
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment with mesoridazine and thioridazine in chronic schizophrenia: I. Assessment of clinical and electrophysiologic responses in refractory hallucinating schizophrenics.
    Gardos G; Tecce JJ; Hartmann E; Bowers P; Cole JO
    Compr Psychiatry; 1978; 19(6):517-25. PubMed ID: 720036
    [No Abstract]   [Full Text] [Related]  

  • 6. Pimozide and the social behavior of schizophrenics.
    Lapierre YD; Lavallee J
    Curr Ther Res Clin Exp; 1975 Jul; 18(1 pt 2):181-88. PubMed ID: 809233
    [No Abstract]   [Full Text] [Related]  

  • 7. Formal thought disorder in schizophrenia. Linguistic, attentional, and intellectual correlates.
    Landre NA; Taylor MA
    J Nerv Ment Dis; 1995 Nov; 183(11):673-80. PubMed ID: 7595428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of dosage ranges of carphenazine and trifluoperazine in elderly chronic schizophrenics.
    Bora G
    Dis Nerv Syst; 1968 Oct; 29(10):695-7. PubMed ID: 4887393
    [No Abstract]   [Full Text] [Related]  

  • 9. The evaluation of chlorpromazine therapy in chronic schizophrenic women. A replicated experiment.
    Ragland R; Clark ML; Ray TS; Paredes A; Costiloe JP; Segal B; Wolf S
    J Chronic Dis; 1968 Oct; 21(6):445-60. PubMed ID: 4879902
    [No Abstract]   [Full Text] [Related]  

  • 10. Phenothiazine effects on psychological and psychophysiological dysfunction in chronic schizophrenics.
    Spohn HE; Lacoursiere RB; Thompson K; Coyne L
    Arch Gen Psychiatry; 1977 Jun; 34(6):633-44. PubMed ID: 326215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flupenthixol and trifluoperazine: a double-blind investigation in the treatment of schizophrenics.
    Gottfries CG
    Br J Psychiatry; 1971 Nov; 119(552):547-8. PubMed ID: 4944664
    [No Abstract]   [Full Text] [Related]  

  • 12. The effect of regressive ECT with process schizophrenics.
    Murillo LG; Exner JE
    Am J Psychiatry; 1973 Mar; 130(3):269-73. PubMed ID: 4143944
    [No Abstract]   [Full Text] [Related]  

  • 13. Further evaluation of small group living program with schizophrenics.
    McGee TF; Williams M; Racusen FR; Cowen J
    Arch Gen Psychiatry; 1968 Dec; 19(6):717-26. PubMed ID: 5714533
    [No Abstract]   [Full Text] [Related]  

  • 14. High dosage trifluoperazine in schizophrenia. Comparison of the efficacy of high and usual doses of trifluoperazine in the treatment of chronic schizophrenics.
    Carscallen HB; Rochman H; Lovegrove TD
    Can Psychiatr Assoc J; 1968 Oct; 13(5):459-61. PubMed ID: 5685522
    [No Abstract]   [Full Text] [Related]  

  • 15. Schizophrenics: the efficacy of phenothiazines.
    McNamee HB
    Am J Psychiatry; 1971 Nov; 128(5):657. PubMed ID: 5114388
    [No Abstract]   [Full Text] [Related]  

  • 16. CT scans and neuropsychological tests as predictors of clinical response in schizophrenics.
    Smith RC; Largen J; Calderon M; Schoolar J; Shvartsburd A; Ravichandran GK
    Psychopharmacol Bull; 1983; 19(3):505-9. PubMed ID: 6138798
    [No Abstract]   [Full Text] [Related]  

  • 17. Neuropsychological patterns in chronic schizophrenia.
    Klonoff H; Fibiger CH; Hutton GH
    J Nerv Ment Dis; 1970 Apr; 150(4):291-300. PubMed ID: 5436955
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of chlorpromazine and trifluoperazine on the activity of chronic schizophrenics.
    Jones IH; Pikler N
    Br J Psychiatry; 1971 Nov; 119(552):545-6. PubMed ID: 4944663
    [No Abstract]   [Full Text] [Related]  

  • 19. Loss of the Kamin blocking effect in acute but not chronic schizophrenics.
    Jones SH; Gray JA; Hemsley DR
    Biol Psychiatry; 1992 Nov; 32(9):739-55. PubMed ID: 1360261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of Tybamate in chronic schizophrenia. (Minor tranquilizers as adjunct therapy in psychosis).
    Serafetinides EA; Clark ML
    Dis Nerv Syst; 1971 Aug; 32(8):567-71. PubMed ID: 5094163
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.